After Clinical Testing at UCLA, Immunotherapy Drug Approved by FDA to Treat Stomach Cancer
University of California, Los Angeles (UCLA), Health SciencesPembrolizumab, a drug that has effectively extended the lives of countless people with many types of cancer, has now been approved by the U.S. Food & Drug Administration to treat people with metastatic gastric adenocarcinoma, the most common form of stomach cancer. The research that led to the approval was conducted at UCLA and 67 other sites in the U.S., Europe, South America and Asia.